Enhanced resistance to Salmonella enterica serovar Typhimurium infection in mice after coumarin treatment

Microbes and Infection

Volumn 9, Issue 1, 2007, Pages 7-14

  Stefanova, Tsvetanka ^a   Nikolova, Nadja ^a   Michailova, Anastasija ^b   Mitov, Ivan ^b   Iancov, Ianco ^b   Zlabinger, Gerhard J ^c   Neychev, Hristo ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Coumarin; Immunomodulators; Salmonella typhimurium

Indexed keywords

COUMARIN; COUMARIN DERIVATIVE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UMBELLIFERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION RESISTANCE; LETHALITY; LIVER; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; SPLEEN;

ANIMALS; COUMARINS; INTERFERON TYPE II; INTERLEUKIN-12; LIVER; MACROPHAGES; MICE; MICE, INBRED BALB C; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; REACTIVE NITROGEN SPECIES; SALMONELLA TYPHI; SPLEEN; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; TYPHOID FEVER; UMBELLIFERONES;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 33846405705     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.10.001     Document Type: Article

References (33)

1. Jamal S., and Casley-Smith J.R. The effects of 5,6-benzo(a)pyrone (coumarin) and DEC on filaritie lymphoedema and elephantiasis in India, preliminari results. Ann. Trop. Med. Parasitol. 83 (1989) 287-290
2. Marshall M.E., Butler K., Cantrel J., Wiseman C., and Mendelson L. Treatment of advanced malignant melanoma with coumarin and cimetidine: A pilot study. J. Cancer Chemother. Pharmacol. 24 (1989) 65-66
3. Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., and Thornes R. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab. Rev. 22 (1990) 503-529
4. Kayser O., Kolodziej H., and Kiderlen A.F. Immunomodulatory principles of Pelargonium sidoides. Phytother. Res. 15 (2001) 122-126
5. Maghraby A., and Bahgat M. Immunostimulatory effect of coumarin derivatives before and after infection of mice with the parasite Schistosoma mansoni. Arzneimittelforschung 54 (2004) 545-550
6. de Souza S.M., Delle Monache F., and Smania Jr. A. Antibacterial activity of coumarins. Z. Naturforsch. [C]. 60 (2005) 693-700
7. Bolton T., and Casley-Smith J.R. An in vitro demonstration of proteolysis by macrophages and its increase with coumarin. Experientia 31 (1975) 271-273
8. Hardt T.J., and Ritschel W.A. The Effect of coumarin and 7-hydroxycoumarin on in vitro macrophage phagocytosis of latex particles. Meth. Find. Exp. Clin. Pharmacol. 5 (1983) 39-43
9. Stuhlmeier K., Theyer G., Baumgartner G., and Zlabinger G.J. Synergistic effect of coumarin (1,2-benzopyrone) and endotoxin in the induction of human interleukin-1. Clin. Exp. Immunol. 84 (1991) 317-323
10. Marshall M.E., Rhoades J.L., Mattingly C., and Jennings C.D. Coumarin (1,2-benzopyrone) enhances DR and DQ antigen expression by peripheral blood mononuclear cells in vitro. Mol. Biother. 3 (1991) 204-206
11. Richter-Dahlfors A., Buchman A.M.J., and Finlay B.B. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J. Exp. Med. 186 (1997) 569-580
12. Vazquez-Torres A., Jones-Carson J., Mastroeni P., Ischiropoulos H., and Fang F.C. Antimicrobial action of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated macrophages in vitro. J. Exp. Med. 192 (2000) 227-236
13. Dharmana E., Keuter M., Netea M.G., Verschueren I.C.M.M., and Kullberg B.J. Divergent effect of tumor necrosis factor-α and lymphotoxin-α on lethal endotoxemia and infection with live Salmonella typhimurium in mice. Eur. Cytokine Netw. 13 (2002) 104-109
14. Jankovic D., Liu Z., and Gause W.C. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 22 (2001) 450-457
15. Khan S.A., Everest P., Servos S., Foxwell N., Zahringer U., Brade H., Rietschel E.T., Dougan G., Charles I.G., and Maskell D.J. A lethal role for lipid A in Salmonella infection. Mol. Microbiol. 29 (1998) 571-579
16. Gumenscheimer M., Mitov I., Galanos C., and Freudenberg M. Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection. Infect. Immun. 70 (2002) 5596-5603
17. Mariencheck W.I., Savov J., Dong Q., Tino M.J., and Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am. J. Physiol. 277 (1999) L777-L786
18. Toshkova R., Nikolova N., Ivanova E., Ivancheva S., and Serkedjieva J. In vitro investigation on the effect of a plant preparation with antiviral activity on the functions of mice phagocyte cells. Pharmazie 59 (2004) 150-154
19. Ritschel W.A., Brady M.E., Tan H.S., Hoffmann K.A., Yiu I.M., and Grummich K.W. Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur. J. Clin. Pharmacol. 12 (1977) 457-461
20. Born S.L., Caudill D., Smith B.J., and Lehman-McKeeman L.D. In vitro kinetics of coumarin 3,4-epoxidation: Application to species differences in toxicity and carcinogenicity. Toxicol. Sci. 58 (2000) 23-31
21. Andrejak M., Sgro C., Decocq G., Hamel J.D., Morin M., and Gras V. French pharmacovigilance survey evaluating the hepatic toxicity of coumarin. Pharmacoepidemiol. Drug Saf. 7 Suppl. 1 (1998) S45-S50
22. Cherayil B.J., and Antos D. Inducible nitric oxide synthase and Salmonella infection. Microbes Infect. 3 (2001) 771-776
23. Mastroeni P., Arena A., Costa G.B., Liberto M.C., Bonina L., and Hormaeche C.E. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb. Pathog. 11 (1991) 33-38
24. Mastroeni P., Harrison J.A., Chabalgoity J.A., and Hormaeche C.E. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect. Immun. 64 (1996) 189-196
25. - Salmonella typhimurium is enhanced by neutralization of γ interferon and tumor necrosis factor α. Infect. Immun. 65 (1997) 5191-5194
26. Kincey-Cain T., Clemens J.D., and Bost U.L. Endogeneous and exogeneous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella Dublin. Infect. Immun. 64 (1996) 1437-1440
27. Stobie L., Gurunatghan S., Prussin C., Sacks S.L., Glaichenhaus N., Wu C.Y., and Seder R.A. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 8427-8432
28. Yap G., Pessin M., and Sher A. Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen Toxoplasma gondii. J. Immunol. 165 (2000) 628-631
29. Kirby A.C., Yrlid U., and Wick M.J. The innate immune response differs in primary and secondary Salmonella infection. J. Immunol. 169 (2002) 4450-4459
30. Mastroeni P., Vasquez-Torres A., Fang F.C., Xu Y., Khan S., Hormaeche C.E., and Dougan G. Antimicrobial action of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192 (2000) 237-245
31. Das G., Sheridan S., and Janeway Jr. C.A. The source of early IFN-γ that plays the role in Th1 priming. J. Immunol. 167 (2001) 2004-2010
32. Chan E.D., Winston B.W., Uh S.T., Wynes M.W., Rose D.M., and Riches D.W. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 162 (1999) 415-422
33. Zlabinger G.J., Nöhammer C., Böhmig G.A., and Menzel J.E. Mode of action of coumarin in immune cells. J. Cancer Res. Clin. Oncol. 120 Suppl (1994) S17-S18